Single Cell Genome Sequencing Market Global Industry Opportunity & Forecast 2018-2028 - Increasing Industry Collaboration and Partnerships


Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Single Cell Genome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ResearchAndMarkets.com's offering.

The Global Single Cell Genome Sequencing Market was valued at USD 2.27 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 15.95% through 2028, reaching USD 5.48 billion.

The Global Single Cell Genome Sequencing Market is a dynamic and rapidly evolving sector within the broader genomics and biotechnology industry. It revolves around the application of cutting-edge techniques to analyze the genomes of individual cells, revealing insights into cellular heterogeneity, genetic mutations, and gene expression patterns.

Key Market Drivers

  • Advancements in Genomic Research
  • Clinical and Diagnostic Applications
  • Technological Advancements
  • Rising Investments and Funding

Key Market Challenges

  • Cost and Accessibility
  • Data Integration and Interpretation
  • Regulatory and Ethical Considerations

Key Market Trends

Expanding Clinical and Diagnostic Applications

The most prominent trends in the Single Cell Genome Sequencing Market is the expanding use of this technology in clinical and diagnostic applications. Single-cell sequencing is being increasingly integrated into healthcare practices, enabling personalized medicine and improving disease diagnosis and monitoring.

Single-cell sequencing is being used to understand the genetic heterogeneity within tumors, aiding in the development of targeted cancer therapies. It allows for the detection of rare cancer cell populations and the tracking of treatment resistance. Single-cell sequencing is being employed in non-invasive prenatal testing (NIPT) for the early detection of chromosomal abnormalities in fetuses. This technology is safer and more accurate than traditional invasive methods like amniocentesis. Single-cell sequencing is being utilized to detect and monitor infectious diseases by identifying pathogens at the single-cell level. This is crucial for tracking disease outbreaks and developing effective treatments and vaccines. Researchers are using single-cell sequencing to study the genetic underpinnings of neurological disorders like Alzheimer's and Parkinson's disease. It provides insights into the heterogeneity of brain cells and disease mechanisms.

Technological Advancements and Automation

Continuous technological advancements are a prominent trend in the single-cell genome sequencing market. These advancements are making the technology more efficient, cost-effective, and accessible to a wider range of researchers and industries.

Sequencing platforms with high throughput are enabling the analysis of a larger number of individual cells simultaneously. This accelerates research and lowers the cost per cell. Manufacturers are developing user-friendly platforms with streamlined workflows and pre-optimized protocols. These platforms make single-cell sequencing more accessible and reduce the barriers to entry for researchers. Technological advancements have enabled the integration of multi-omics data from single cells, allowing researchers to simultaneously analyze genomics, transcriptomics, epigenomics, and proteomics data. The emergence of spatial transcriptomics, made possible by technological advancements, enables the study of the spatial organization of individual cells within tissues, providing insights into the spatial context of gene expression.

Industry Collaboration and Partnerships

Collaboration and partnerships between biotechnology and pharmaceutical companies, research institutions, and academic organizations are another key trend driving the growth of the Single Cell Genome Sequencing Market.

Biotechnology and pharmaceutical companies are increasingly partnering with research institutions to develop diagnostics and therapies based on single-cell sequencing data. This collaboration accelerates the translation of research findings into practical applications. Government agencies and non-profit organizations are promoting global collaboration in genomics research. Funding often comes with requirements for international cooperation, fostering knowledge sharing and cross-border research. Initiatives aimed at sharing single-cell sequencing data are on the rise. Open-access databases and data-sharing platforms make valuable data available to the wider scientific community, facilitating further research and innovation.

Report Scope

In this report, the Global Single Cell Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single Cell Genome Sequencing Market, By Product Type:

  • Instruments
  • Reagents

Single Cell Genome Sequencing Market, By Technology:

  • NGS
  • PCR
  • qPCR
  • Microarray
  • MDA

Single Cell Genome Sequencing Market, By Workflow:

  • NGS
  • PCR
  • qPCR
  • Microarray
  • MDA

Single Cell Genome Sequencing Market, By Disease Area:

  • Cancer
  • Immunology
  • Prenatal Diagnosis
  • Neurobiology
  • Microbiology
  • Others

Single Cell Genome Sequencing Market, By Application:

  • Circulating Cells
  • Cell Differentiation/Reprogramming
  • Genomic Variation
  • Subpopulation Characterization
  • Others

Single Cell Genome Sequencing Market, By End-User:

  • Academic & Research Laboratories
  • Biotechnology & Biopharmaceutical Companies
  • Clinics
  • Others

Company Profiles:

Detailed analysis of the major companies present in the Global Single Cell Genome Sequencing Market.

  • Bio-Rad Laboratories Inc
  • 10x Genomics Inc
  • Novogene Co. Ltd
  • BGI Genomics Co Ltd.
  • Illumina, Inc.
  • Oxford Nanopore Technologies Plc
  • Pacific Biosciences Laboratories Inc
  • Thermo Fisher Scientific, Inc.
  • QIAGEN GmbH
  • F. Hoffmann-La-Roche Ltd

Key Attributes:

Report AttributeDetails
No. of Pages182
Forecast Period2022 - 2028
Estimated Market Value (USD) in 2022$2.27 Billion
Forecasted Market Value (USD) by 2028$5.48 Billion
Compound Annual Growth Rate15.9%
Regions CoveredGlobal

For more information about this report visit https://www.researchandmarkets.com/r/t0se9d

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Coordonnées